Estrella Immunopharma (ESLA) Assets Average (2021 - 2026)
Estrella Immunopharma (ESLA) posted quarterly Assets Average of $3.4 million for Q1 2026, up 22.37% year-over-year from $2.8 million in Q1 2025, and up 2.0% quarter-over-quarter from $3.4 million in Q4 2025.
Estrella Immunopharma (ESLA) Assets Average (2021 - 2026) Analysis & Trends
Estrella Immunopharma (ESLA) has reported Assets Average for 6 consecutive years, with $3.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average rose 22.37% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (up 22.37% YoY), while the FY2025 annual figure was $3.2 million, down 16.82% from the prior year.
- Assets Average grew to $3.4 million in Q1 2026 per ESLA's latest filing, from $3.4 million in the prior quarter.
- Across five years, Assets Average topped out at $45.7 million in Q1 2022 and bottomed at $2.7 million in Q2 2025.
- Historically, Assets Average has averaged $14.9 million across 5 years, with a median of $6.5 million in 2024.
- Annual changes were most pronounced in 2023 — Assets Average plunged 85.92% — and 2026, when it advanced 22.37%.
- Estrella Immunopharma's Assets Average stood at $27.7 million in 2022, then slumped by 33.51% to $18.4 million in 2023, then sank by 81.31% to $3.4 million in 2024, then declined by 2.55% to $3.4 million in 2025, then gained by 2.0% to $3.4 million in 2026.
- Business Quant data shows ESLA's Assets Average at $3.4 million in Q1 2026, $3.4 million in Q4 2025, and $3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.87 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.40 Bn | 60.22 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.36 Bn | 54.22 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.91 Bn | 28.60 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.17 Bn | 9.78 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Estrella Immunopharma | 32.29 Mn | 32.14 Mn | - | 2.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.74 Mn |
| Mar 31, 2026 | 3.42 Mn |
| Dec 31, 2025 | 3.35 Mn |
| Sep 30, 2025 | 3.25 Mn |
| Jun 30, 2025 | 2.71 Mn |
| Mar 31, 2025 | 2.79 Mn |
| Dec 31, 2024 | 3.44 Mn |
| Sep 30, 2024 | 4.09 Mn |
| Jun 30, 2024 | 6.54 Mn |
| Mar 31, 2024 | 9.04 Mn |
| Dec 31, 2023 | 18.40 Mn |
| Sep 30, 2023 | 15.19 Mn |
| Jun 30, 2023 | 6.40 Mn |
| Mar 31, 2023 | 9.75 Mn |
| Dec 31, 2022 | 27.67 Mn |
| Sep 30, 2022 | 45.50 Mn |
| Jun 30, 2022 | 45.50 Mn |
| Mar 31, 2022 | 45.71 Mn |
| Dec 31, 2021 | 45.89 Mn |